Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)

Inflammatory bowel diseases (IBDs), divided into two predominant groups, Crohn’s disease (CD) and ulcerative colitis (UC), are chronic relapsing inflammatory diseases of the gastrointestinal tract, resulting from an aberrant immune response to microbes in the gut, in genetically susceptible patients...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2022-07, Vol.11 (15), p.4374
Main Authors: Furfaro, Federica, Ragaini, Elisa, Peyrin-Biroulet, Laurent, Danese, Silvio
Format: Article
Language:English
Subjects:
Clinical medicine
Clinical trials
Conflicts of interest
Crohn's disease
Drugs
Endoscopy
Gastroenterology
Inflammatory bowel disease
Kinases
Life Sciences
Monoclonal antibodies
Patients
Pharmaceuticals
Remission (Medicine)
Tumor necrosis factor-TNF
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Inflammatory bowel diseases (IBDs), divided into two predominant groups, Crohn’s disease (CD) and ulcerative colitis (UC), are chronic relapsing inflammatory diseases of the gastrointestinal tract, resulting from an aberrant immune response to microbes in the gut, in genetically susceptible patients [...]
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm11154374